@ShahidNShah
The Search For New COPD Therapies
The COPD Foundation is calling for a change in clinical trial design that would test experimental therapies in subsets of patients.
As many as 30 million people in the United States are estimated to have chronic obstructive pulmonary disease (COPD), although approximately half don’t have a diagnosis. Until the COVID-19 pandemic, COPD was consistently the fourth leading cause of death in the U.S. Diagnosis and treatment is complicated by the fact that COPD is really something of an umbrella category for lung disease that is characterized by difficulty breathing. The two most common conditions that fit under the COPD rubric include emphysema and chronic bronchitis.
The current treatment choices for COPD are varied and complicated, mirroring the condition itself. But in broad strokes, they can be grouped into three main medication categories:
Continue reading at managedhealthcareexecutive.com
Make faster decisions with community advice
- Improving Inventory Management During COVID-19 and Beyond
- What’s On The Horizon For Drug Development In 2021?
- Going To The Molecular Level To Think Big About Cancer
- What Does Remote Patient Monitoring and Chronic Care Management Really Take to Be Successful?
- Why Aren’t We Using HIEs to Support Vaccination Efforts (and Everything Else)? w/ Niam Yaraghi - The #HCBiz Show
Next Article
-
What’s On The Horizon For Drug Development In 2021?
The industry is adjusting to the pandemic, but FDA approvals could dip this year. Several new drugs for atopic dermatitis may get the agency’s green light. Like so much else in healthcare and beyond, …
Posted Mar 3, 2021 Drug Development